Leveraging high-throughput analytics and automation to rapidly develop high-concentration mAb formulations: integrated excipient compatibility and viscosity screening
- DOI
- 10.1093/abt/tbae028
- Published
- 2024-10
- Container
- Antibody Therapeutics
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/abt/tbae028,
title = {Leveraging high-throughput analytics and automation to rapidly develop high-concentration mAb formulations: integrated excipient compatibility and viscosity screening},
author = {Lun Xin and Lan Lan and Mourad Mellal and Nathan McChesney and Robert Vaughan and Claudia Berdugo and Yunsong Li and Jingtao Zhang},
year = {2024},
journal = {Antibody Therapeutics},
doi = {10.1093/abt/tbae028},
url = {https://doi.org/10.1093/abt/tbae028}
}RIS
TY - JOUR TI - Leveraging high-throughput analytics and automation to rapidly develop high-concentration mAb formulations: integrated excipient compatibility and viscosity screening AU - Lun Xin AU - Lan Lan AU - Mourad Mellal AU - Nathan McChesney AU - Robert Vaughan AU - Claudia Berdugo AU - Yunsong Li AU - Jingtao Zhang PY - 2024 JO - Antibody Therapeutics DO - 10.1093/abt/tbae028 UR - https://doi.org/10.1093/abt/tbae028 ER -
APA
Xin, L., Lan, L., Mellal, M., McChesney, N., Vaughan, R., Berdugo, C., Li, Y., & Zhang, J. (2024). Leveraging high-throughput analytics and automation to rapidly develop high-concentration mAb formulations: integrated excipient compatibility and viscosity screening. Antibody Therapeutics. https://doi.org/10.1093/abt/tbae028
Source records
- crossref · retrieved 2026-09-26T20:20:18.974Z